Follow the people · Insider

DL

Daniel S. Lorrain

Insider · Chief Scientific Officer · CTNM

Daniel S. Lorrain files insider transactions with the SEC as a chief scientific officer of Contineum Therapeutics (CTNM). We hold 14 disclosed purchases and sales filed since 29 May 2024, 4 of them in the last 90 days.

  • Files forCTNM
  • Disclosed buys and sells14 in all, 4 in the last 90 days
  • Last disclosure10 July 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 24 May 20249 July 2026Chief Scientific Officer · Contineum Therapeutics (CTNM)63 Form 4 lines · source: SEC Form 4

Everything they disclosed

63 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.